{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:07:14Z","timestamp":1793855234329,"version":"4.6.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/jcp.0b013e318172b8d5","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T08:43:21Z","timestamp":1236242601000},"page":"279-288","source":"Crossref","is-referenced-by-count":184,"title":["Maternal Use of Antipsychotics in Early Pregnancy and Delivery Outcome"],"prefix":"10.1097","volume":"28","author":[{"given":"Margareta","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"K\u00e4ll\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/0140-6736(93)91415-I","article-title":"Sexual selection, Machiavellian intelligence, and the origin of psychosis.","volume":"342","author":"Crow","year":"1993","journal-title":"Lancet"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.2007.06111886","article-title":"Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes.","volume":"164","author":"Newport","year":"2007","journal-title":"Am J Psychiatry"},{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2165\/00002018-200629070-00004","article-title":"Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetics and adverse effect profiles?","volume":"29","author":"Aichhorn","year":"2006","journal-title":"Drug Saf"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/00002018-200629040-00002","article-title":"Long term atypical antipsychotics treatment and risk of weight gain. A literature analysis.","volume":"29","author":"Gentile","year":"2006","journal-title":"Drug Saf"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jpsychires.2006.08.007","article-title":"Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.","volume":"41","author":"Zhang","year":"2007","journal-title":"J Psychiatr Res"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2007.10.022","article-title":"Weight gain induced by haloperidol, risperidone and olanzapine after 1 year: findings of a randomised clinical trial in a drug-naive population.","volume":"99","author":"Perez-Iglesias","year":"2007","journal-title":"Schizophr Res"},{"issue":"suppl 3","key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.euroneuro.2006.06.003","article-title":"Differential metabolic effects of antipsychotic treatments.","volume":"16","author":"Haupt","year":"2006","journal-title":"Europ Neuropsychopharmacol"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-5618.2006.00295.x","article-title":"Prophylactic treatment of bipolar disorders in pregnancy and breastfeeding: focus on emerging mood stabilizers.","volume":"8","author":"Gentile","year":"2006","journal-title":"Bipolar Disord"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-3016.2000.00274.x","article-title":"Maternal height and prepregnancy body mass index as risk factors for selected congenital malformations.","volume":"14","author":"Shaw","year":"2000","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R10-5-20210128","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/oby.2003.146","article-title":"Maternal obesity and infant heart defects.","volume":"11","author":"Cedergren","year":"2003","journal-title":"Obesity Res"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archpsyc.58.7.674","article-title":"Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia.","volume":"58","author":"Bennedsen","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.schres.2007.07.018","article-title":"Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study.","volume":"97","author":"Byrne","year":"2007","journal-title":"Schizophr Res"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1469-7610.2006.01714.x","article-title":"Antenatal maternal stress and long-term effects on child neurodevelopment: how and why?","volume":"48","author":"Talge","year":"2007","journal-title":"J Child Psychol Psychiatry"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JRS-2001-263","article-title":"Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias?","volume":"14","author":"Kallen","year":"2001","journal-title":"Int J Risk Safety Med"},{"key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF01719316","article-title":"A birth weight for gestational age standard based on data in the Swedish medical birth registry 1985-1989.","volume":"11","author":"Kallen","year":"1995","journal-title":"Eur J Epidemiol"},{"key":"R18-5-20210128","first-page":"719","article-title":"Statistical aspects of the analyses of data from retrospective studies of disease.","volume":"22","author":"Mantel","year":"1959","journal-title":"J Nat Cancer Inst"},{"key":"R19-5-20210128","first-page":"515","article-title":"Simple interval estimation of risk ratio.","volume":"100","author":"Miettinen","year":"1974","journal-title":"Am J Epidemiol"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1067\/mob.2002.122596","article-title":"Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting in pregnancy (NVP).","volume":"186","author":"Magee","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00228-005-0055-1","article-title":"Use of antiemetic drugs during pregnancy in Sweden.","volume":"61","author":"Asker","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0895-4356(96)00203-X","article-title":"Use of psychotropic drugs and pregnancy outcome.","volume":"49","author":"Larivaara","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-5618.2007.00382.x","article-title":"Adverse pregnancy outcomes in mothers with affective psychosis.","volume":"9","author":"MacCabe","year":"2007","journal-title":"Bipolar Disord"},{"key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1517\/14740338.6.4.357","article-title":"The safety of antidepressant drugs during pregnancy.","volume":"6","author":"Kallen","year":"2007","journal-title":"Expert Opin Drug Saf"},{"key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0890-6238(94)00069-7","article-title":"An assessment of lithium using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents. IEHR Expert Scientific Committee.","volume":"9","author":"Moore","year":"1995","journal-title":"Reprod Toxicol"},{"key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.2174\/138161206776389804","article-title":"Teratogenic and developmental effects of lithium.","volume":"12","author":"Giles","year":"2006","journal-title":"Curr Pharm Des"},{"key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1067\/mob.2002.123610","article-title":"Case report and review of perinatal implications of maternal lithium use.","volume":"187","author":"Pinelli","year":"2002","journal-title":"Am J Obst Gynecol"},{"key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/tera.1420150108","article-title":"Possible teratogenic effect of phenothiazines in human beings.","volume":"15","author":"Rumeau-Rouquette","year":"1977","journal-title":"Teratology"},{"key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9378(77)90029-1","article-title":"Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score.","volume":"128","author":"Sloane","year":"1977","journal-title":"Am J Obst Gynecol"},{"key":"R31-5-20210128","first-page":"291","article-title":"Safety evaluation of haloperidol in the treatment of hyperemesis gravidarum.","volume":"9","author":"Van Waes","year":"1969","journal-title":"J Clin Pharmacol"},{"key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4088\/JCP.v66n0307","article-title":"Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.","volume":"66","author":"Diav-Citrin","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bmj.317.7162.839","article-title":"Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies.","volume":"317","author":"Dolovich","year":"1998","journal-title":"BMJ"},{"issue":"suppl 4","key":"R34-5-20210128","first-page":"42","article-title":"The reproductive safety profile of mood stabilizers, atypical antipsychotics, and broad-spectrum psychotropics.","volume":"63","author":"Ernst","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4088\/JCP.v66n0406","article-title":"Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.","volume":"66","author":"McKenna","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","article-title":"Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.","volume":"16","author":"Wikner","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00002018-200730030-00006","article-title":"Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcome.","volume":"30","author":"Coppola","year":"2007","journal-title":"Drug Saf"},{"key":"R38-5-20210128","first-page":"497","article-title":"Psychotropics in pregnancy: weighing the risks.","volume":"123","author":"Grover","year":"2006","journal-title":"Indian J Med Res"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200806000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:27:59Z","timestamp":1738960079000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200806000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318172b8d5","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}